Matches in Wikidata for { <http://www.wikidata.org/entity/Q93074505> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q93074505 description "2018 թվականի նոյեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q93074505 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93074505 description "scientific article published on 11 November 2018" @default.
- Q93074505 description "wetenschappelijk artikel" @default.
- Q93074505 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93074505 name "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 name "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 type Item @default.
- Q93074505 label "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 label "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 prefLabel "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 prefLabel "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 P1433 Q93074505-51FE52FB-59BC-400A-B9CB-347808E2E600 @default.
- Q93074505 P1476 Q93074505-3855823D-AF27-4D60-80B4-EE92BB83CB48 @default.
- Q93074505 P2093 Q93074505-14564D24-B8C4-45E8-8CE6-2CD4E1EA44E1 @default.
- Q93074505 P2093 Q93074505-14F80E2F-6752-491F-95FD-B53340DF42F7 @default.
- Q93074505 P2093 Q93074505-1B6849CC-F0B2-48A2-8662-06661EDE2D06 @default.
- Q93074505 P2093 Q93074505-2E619D69-53A7-411A-9EA4-70192D1E78E8 @default.
- Q93074505 P2093 Q93074505-35748520-198B-438B-8CF9-67F753952744 @default.
- Q93074505 P2093 Q93074505-3E722E58-52F2-4D99-B24E-8C02C54B5F4C @default.
- Q93074505 P2093 Q93074505-4219BD6C-9217-4F9E-942F-1E0EA6471018 @default.
- Q93074505 P2093 Q93074505-486D4A9F-86BC-4332-B482-5BDCE17D90E3 @default.
- Q93074505 P2093 Q93074505-5D856314-314B-4279-9CDF-763788B75259 @default.
- Q93074505 P2093 Q93074505-63B8F037-B318-4EA4-8C6D-BE3D6D7A1B45 @default.
- Q93074505 P2093 Q93074505-6FB6CA9C-0D45-4E53-8DD3-288CCEE13064 @default.
- Q93074505 P2093 Q93074505-7080A481-8A17-458F-BCBC-35124870E453 @default.
- Q93074505 P2093 Q93074505-7112FFE3-69FA-42B9-ABD1-E2986948208E @default.
- Q93074505 P2093 Q93074505-821441AA-AECB-4EA7-9D85-C276AA9AFBCF @default.
- Q93074505 P2093 Q93074505-92025363-5486-4261-AED2-3C5E3A3CB5CA @default.
- Q93074505 P2093 Q93074505-9D7F9975-C937-4BC6-8A5A-36A4319BA386 @default.
- Q93074505 P2093 Q93074505-B1107ABA-7CBE-411A-A4C6-FF46A2636312 @default.
- Q93074505 P2093 Q93074505-CF60D22E-1DF6-4646-A19E-71954FBB4BFA @default.
- Q93074505 P2093 Q93074505-D073329E-9C86-453C-BA35-51B558B50D36 @default.
- Q93074505 P2093 Q93074505-E092952E-538C-421B-9636-4182CB0D0F06 @default.
- Q93074505 P2093 Q93074505-FFD78E2C-17B4-4C68-9467-8021B6C17618 @default.
- Q93074505 P304 Q93074505-A48B8D7A-2C4E-4DE9-977C-DA267C3619E7 @default.
- Q93074505 P31 Q93074505-C1B6C843-7309-4613-B862-D6BD740C2918 @default.
- Q93074505 P356 Q93074505-F872D5D2-0433-4F51-80B9-BB2D8D1EE622 @default.
- Q93074505 P433 Q93074505-D923B6D0-5D43-4A2D-AD66-C45084BCF105 @default.
- Q93074505 P478 Q93074505-DAFF21B2-60EB-4AD4-B077-0254E3CD2BD4 @default.
- Q93074505 P50 Q93074505-396E9EE9-509C-49A0-8E84-65527014F627 @default.
- Q93074505 P50 Q93074505-3987E9E8-209E-40ED-92A2-805B7B4654D7 @default.
- Q93074505 P50 Q93074505-91F70F6A-BCB1-4314-A963-30A41E5D6716 @default.
- Q93074505 P50 Q93074505-CD4D3E78-3AEE-4109-AFF6-1DE637A85073 @default.
- Q93074505 P577 Q93074505-E2AD4E68-D6EB-435D-93B7-5A2EDA85D4D3 @default.
- Q93074505 P698 Q93074505-F604F5D9-C294-46BF-989B-97427881F722 @default.
- Q93074505 P356 J.JACC.2018.10.039 @default.
- Q93074505 P698 30428396 @default.
- Q93074505 P1433 Q2984355 @default.
- Q93074505 P1476 "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial" @default.
- Q93074505 P2093 "Angèle Moryusef" @default.
- Q93074505 P2093 "Chern-En Chiang" @default.
- Q93074505 P2093 "Corinne Hanotin" @default.
- Q93074505 P2093 "Deepak L Bhatt" @default.
- Q93074505 P2093 "Denis Xavier" @default.
- Q93074505 P2093 "Gregory G Schwartz" @default.
- Q93074505 P2093 "Guillaume Lecorps" @default.
- Q93074505 P2093 "Jay M Edelberg" @default.
- Q93074505 P2093 "Kenneth W Mahaffey" @default.
- Q93074505 P2093 "Marco Alings" @default.
- Q93074505 P2093 "Michael Szarek" @default.
- Q93074505 P2093 "ODYSSEY OUTCOMES Committees and Investigators" @default.
- Q93074505 P2093 "Ph Gabriel Steg" @default.
- Q93074505 P2093 "Pierluigi Tricoci" @default.
- Q93074505 P2093 "Rafael Diaz" @default.
- Q93074505 P2093 "Robert A Harrington" @default.
- Q93074505 P2093 "Robert Gabor Kiss" @default.
- Q93074505 P2093 "Robert Pordy" @default.
- Q93074505 P2093 "Shaun G Goodman" @default.
- Q93074505 P2093 "Takeshi Kimura" @default.
- Q93074505 P2093 "Vera A Bittner" @default.
- Q93074505 P304 "387-396" @default.
- Q93074505 P31 Q13442814 @default.
- Q93074505 P356 "10.1016/J.JACC.2018.10.039" @default.
- Q93074505 P433 "4" @default.
- Q93074505 P478 "73" @default.
- Q93074505 P50 Q1587897 @default.
- Q93074505 P50 Q501318 @default.
- Q93074505 P50 Q64684757 @default.
- Q93074505 P50 Q64858750 @default.
- Q93074505 P577 "2018-11-11T00:00:00Z" @default.
- Q93074505 P698 "30428396" @default.